Mohamed Touati

Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial

Luc‐Matthieu Fornecker, Julien Lazarovici, Igor Aurer et al. · Journal of Clinical Oncology · 2022 · 75 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Sideroblastic anemia: molecular analysis of the ALAS2 gene in a series of 29 probands and functional studies of 10 missense mutations

Sarah Ducamp, Caroline Kannengiesser, Mohamed Touati et al. · Human Mutation · 2011 · 69 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up

Jérôme Paillassa, Édouard Cornet, Stéphanie Noël et al. · Blood Cancer Journal · 2020 · 59 citations · Full text

Medicine, Oncology, Pharmacology +13

Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome

Mariane de Montalembert, Jean-Antoine Ribeil, Valentine Brousse et al. · PLoS ONE · 2017 · 56 citations · Full text

Medicine, Hematology, Internal Medicine +14

Early ¹⁸F-FDG PET/CT Response Predicts Survival in Relapsed or Refractory Hodgkin Lymphoma Treated with Nivolumab

Aiping Chen, Fatima‐Zohra Mokrane, Lawrence H. Schwartz et al. · Journal of Nuclear Medicine · 2019 · 46 citations · Full text

Medicine, Nuclear Medicine, Oncology +17